UK health minister pledges ambitious new anti-smoking legislation plan

Oct.23.2024
UK health minister pledges ambitious new anti-smoking legislation plan
The UK Health Secretary has announced plans to introduce tougher anti-smoking laws, with the aim of gradually raising the legal age to buy tobacco so that those born after 2009 will never be able to legally smoke, with the aim of creating a 'smoke-free generation' by 2025.

British Health Secretary Wes Streeting pledged to tighten smoking laws with a "more ambitious" bill during a new NHS consultation event he attended with British Prime Minister Sir Keir Starmer, according to a report in The Independent on 21 October.


The plan is expected to be announced in 2025 and will make greater use of data and technology. Streeting said the combination of genetic testing, artificial intelligence (AI), machine learning and big data will help predict and prevent disease.

 

He highlighted that new legislation will gradually raise the legal age to buy tobacco, with the aim of preventing people born after 1 January 2009 from legally smoking.

 

Streeting told reporters at a medical facility in East London on Monday (21): "We will introduce the tobacco and e-cigarettes bill before Christmas. In fact, discussions on tobacco and e-cigarette measures have already started and we are listening to the public".

 

In addition, the UK government is considering a smoking ban, which has caused concern in certain sectors of the entertainment industry.

 

Streeting pointed out that the balance between public health benefits and personal freedoms and commercial interests needs to be addressed. 

 

"When the new anti-smoking legislation is introduced, it will be more ambitious than the previous government's bill, with the significant importance being that the children growing up now will become the first "smoke-free generation." This change will greatly impact one of the biggest health threats in our country," he said.

 

In addition, charities and health experts have expressed disappointment that the bill was shelved after the election. 

 

Hazel Cheeseman, chief executive of Action on Smoking and Health, said in a statement: "This will be legislation that all politicians involved will be proud of for years to come."


"The debate on the scope of the new legislation is crucial. But the real debate must not be undermined by those with commercial interests hiding behind liberal arguments. There is no freedom in addiction.
 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spain’s Popular Party and Socialist Party reached an agreement in the Joint Congress-Senate Commission for the Study of Addiction Problems and approved a non-binding motion calling for the sale of e-cigarettes, nicotine pouches and related products to be limited to authorized and controlled channels, such as tobacco shops and specialized stores, while excluding internet sales and general retail outlets.
Apr.27 by 2FIRSTS.ai
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12